幸运52官方app-首页

幸运52官方app

中文

新聞

醋酸阿比特龍片出口美國
The first Avastin(Bevacizumab) Biosimilar approval in China granted by NMPA
齊魯藥業在中國制藥百強企業中排名第八
Qilu Pharmaceutical recognized as Top 3 domestic R&D pharmaceutical company of 2019
Qilu Pharma Announces Launch of a Generic Version of Vesicare® in the United States
Qilu Pharma Announces Launch of a Generic Version of Cialis ® in the United States
哌拉西林鈉/他唑巴坦鈉出口到美國

産品展示

制造業

新聞

聯系我們

R&D 

關于我們

南国娱乐大厅 Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. 魯ICP備06006222号 Headquarter Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China

baiduxml 957平台娱乐